Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Overactive Detrusor: later-stage trial registry

1 of 2 indexed Overactive Detrusor trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Overactive Detrusor: 2 US clinical trials tracked, 1 recruiting.

Overactive Detrusor is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is AbbVie, running 1 of these trials.

Enrollment posture brief

Registry condition overactive-detrusor

OPEN 1 | RECR 50% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Overactive Detrusor (this)50%
Open-enrollment share among volume-matched conditions near Overactive Detrusor

Overactive Detrusor lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Overactive Detrusor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Overactive Detrusor is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

AbbVie 1 trials
Duke University 1 trials

Named interventions

Most-linked intervention names on Overactive Detrusor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Oxybutynin Drug
1 trials
Yoga Behavioral
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Overactive Detrusor trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Virginia 1 trials
Texas 1 trials
Oregon 1 trials
New York 1 trials
Mississippi 1 trials
Georgia 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Overactive Detrusor page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Overactive Detrusor trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • AbbVie sponsors the most Overactive Detrusor trials on record, review their full trial history before evaluating a specific study. See AbbVie's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Overactive Detrusor condition card totals 2 registered trials; most-linked intervention Oxybutynin; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.